Current Edition

Modern Tools to Advance
Editorial Archive

Modern Tools to Advance Generic Drug Development and Review

Generic prescription drugs that are approved by the FDA have the same high quality and strength as brand-name drugs. Likewise, the manufacturing and packaging sites …

Continue Reading →
Gene Therapy in Rare Diseases
Editorial Archive

Gene Therapy in Rare Diseases

Many rare diseases are “monogenic” – that is, they are the consequence of a defect in a single gene. Daniel Mazzolenis and Jozsef Palatka at …

Continue Reading →
Patient Safety Monitoring
Editorial Archive

Patient Safety Monitoring and Beyond

Whether enabling new approaches to patient safety monitoring and clinical trials, or improving success rates for regulatory submissions, artificial intelligence (AI) offers enormous potential to …

Continue Reading →
FDA Guidance Recommends Diversity
Editorial Archive

FDA Guidance Recommends Diversity in Clinical Trials, but Can’t Require It

The US Food and Drug Administration (FDA) frequently stress the importance of enrolling diverse patient populations in clinical trials conducted to support product applications. Meg …

Continue Reading →
Intellectual Property Strategies Crucial
Editorial Archive

Intellectual Property Strategies ‘Crucial’ to Protecting Future of Medical Innovation

Robust intellectual property protection is essential to safeguarding the future of revolutionary biomedical innovations, which transform healthcare for millions of people worldwide. Jim Robertson and …

Continue Reading →
The Lay Summary
Editorial Archive

The Lay Summary – Remember the Reader

As part of its Clinical Trial Transparency initiative, the EMA mandated a requirement for clinical trial sponsors to prepare a summary of the results of …

Continue Reading →
Regulations and Recruitment
Editorial Archive

Regulations and Recruitment: Challenges and Experiences in Bulgaria

Rossen Mihaylov at Ramus Medical discusses the challenges faced during the preparation and conduct of clinical investigations. For both medical drugs and devices, CROs face …

Continue Reading →
eClinical_How One Major BioPharma
Editorial Archive

eClinical: How One Major BioPharma Company is Embracing the New World of Digital Clinical Research

The major objective of pharmaceutical research & development is to bring new health solutions to people who need them. Lionel Bascles and Victoria (Vicky) DiBiaso …

Continue Reading →
Challenges with Cash management
Editorial Archive

Challenges with Cash Management and Reforecasting Clinical Trials

Clinical trials are becoming increasingly complex, particularly with broader scopes, globalisation, changing and expanding regulatory requirements and a greater number of players, such as contract …

Continue Reading →
Pre-clinical Data Analisys Ensuring
Editorial Archive

Pre-clinical Data Analysis Ensuring Relevant First-in-Human Clinical Trials

The first-in-human trial (FIH) is an important milestone in the development of a potential new drug. Nariné Baririan at SGS discusses how going ahead with …

Continue Reading →